标题
Emerging targets of disease-modifying therapy for systemic sclerosis
作者
关键词
-
出版物
Nature Reviews Rheumatology
Volume 15, Issue 4, Pages 208-224
出版商
Springer Nature
发表日期
2019-02-22
DOI
10.1038/s41584-019-0184-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Review article: novel oral-targeted therapies in inflammatory bowel disease
- (2018) J. R. White et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis
- (2018) Christopher P Denton et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of rituximab in systemic sclerosis: French retrospective study and literature review
- (2018) Mathilde Thiebaut et al. AUTOIMMUNITY REVIEWS
- Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow Transplantation
- (2018) Keith M. Sullivan et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- A Potent and Specific CD38 Inhibitor Ameliorates Age-Related Metabolic Dysfunction by Reversing Tissue NAD + Decline
- (2018) Mariana G. Tarragó et al. Cell Metabolism
- Chemokines in systemic sclerosis
- (2018) Jamie King et al. IMMUNOLOGY LETTERS
- Endogenous ligands of TLR4 promote unresolving tissue fibrosis: Implications for systemic sclerosis and its targeted therapy
- (2018) Swati Bhattacharyya et al. IMMUNOLOGY LETTERS
- Dendritic cells in systemic sclerosis: Advances from human and mice studies
- (2018) Alsya J. Affandi et al. IMMUNOLOGY LETTERS
- Toll Like Receptors in systemic sclerosis: An emerging target
- (2018) Steven O’Reilly IMMUNOLOGY LETTERS
- JAK-STAT signaling pathway inhibition: a role for treatment of discoid lupus erythematosus and dermatomyositis
- (2018) Jared S. Kahn et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Anti-fibrotic effects of pirfenidone by interference with the hedgehog signalling pathway in patients with systemic sclerosis-associated interstitial lung disease
- (2018) Hua Xiao et al. International Journal of Rheumatic Diseases
- Mechanosensing and fibrosis
- (2018) Daniel J. Tschumperlin et al. JOURNAL OF CLINICAL INVESTIGATION
- Therapeutic Targeting of TAZ and YAP by Dimethyl Fumarate in Systemic Sclerosis Fibrosis
- (2018) Tetsuo Toyama et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Translational and clinical advances in JAK-STAT biology: The present and future of jakinibs
- (2018) Massimo Gadina et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The use of JAK inhibitors in the treatment of progressive systemic sclerosis
- (2018) S.C. Deverapalli et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- The big five in fibrosis: Macrophages, myofibroblasts, matrix, mechanics, and miscommunication
- (2018) Pardis Pakshir et al. MATRIX BIOLOGY
- Existing and novel biomarkers for precision medicine in systemic sclerosis
- (2018) Peter J. Wermuth et al. Nature Reviews Rheumatology
- Type I interferon in rheumatic diseases
- (2018) Theresa L. Wampler Muskardin et al. Nature Reviews Rheumatology
- Cannabinoids for the treatment of rheumatic diseases — where do we stand?
- (2018) Daphna Katz-Talmor et al. Nature Reviews Rheumatology
- Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
- (2018) Keith M. Sullivan et al. NEW ENGLAND JOURNAL OF MEDICINE
- T follicular helper–like cells contribute to skin fibrosis
- (2018) Devon K. Taylor et al. Science Translational Medicine
- The Pharmacology of CD38/NADase: An Emerging Target in Cancer and Diseases of Aging
- (2018) Eduardo N. Chini et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Fibrotic microtissue array to predict anti-fibrosis drug efficacy
- (2018) Mohammadnabi Asmani et al. Nature Communications
- Matrix Stiffness: the Conductor of Organ Fibrosis
- (2018) Alba Santos et al. Current Rheumatology Reports
- Treatment algorithms for systemic sclerosis according to experts
- (2018) Andreu Fernández-Codina et al. Arthritis & Rheumatology
- Double-blind, Randomized, 8-week Placebo-controlled followed by a 16-week open label extension study, with the LPA1 receptor antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic Sclerosis
- (2018) Yannick Allanore et al. Arthritis & Rheumatology
- Baseline plasma cell gene signature predicts improvement in systemic sclerosis skin scores following treatment with inebilizumab (MEDI-551) and correlates with disease activity in systemic lupus and chronic obstructive pulmonary disease
- (2018) Katie Streicher et al. Arthritis & Rheumatology
- Metformin and Autoimmunity: A “New Deal” of an Old Drug
- (2018) Francesco Ursini et al. Frontiers in Immunology
- BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance
- (2018) Takashi Matsushita et al. Science Advances
- The Role of Oxidative Stress in the Development of Systemic Sclerosis Related Vasculopathy
- (2018) Amaal E. Abdulle et al. Frontiers in Physiology
- Vascular Leaking, a Pivotal and Early Pathogenetic Event in Systemic Sclerosis: Should the Door Be Closed?
- (2018) Cosimo Bruni et al. Frontiers in Immunology
- New insights into the genetics and epigenetics of systemic sclerosis
- (2018) Chiara Angiolilli et al. Nature Reviews Rheumatology
- Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension
- (2017) Sean Gaine et al. EUROPEAN RESPIRATORY JOURNAL
- Small molecule therapy for managing moderate to severe psoriatic arthritis
- (2017) Luisa Costa et al. EXPERT OPINION ON PHARMACOTHERAPY
- Pirfenidone exerts antifibrotic effects through inhibition of GLI transcription factors
- (2017) Miroslava Didiasova et al. FASEB JOURNAL
- Unfolding the pathogenesis of scleroderma through genomics and epigenomics
- (2017) Pei-Suen Tsou et al. JOURNAL OF AUTOIMMUNITY
- Inhibition of β-Catenin Signaling in the Skin Rescues Cutaneous Adipogenesis in Systemic Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial of C-82
- (2017) Robert Lafyatis et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Role of B cells in the pathogenesis of systemic sclerosis
- (2017) S. Sanges et al. REVUE DE MEDECINE INTERNE
- Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis
- (2017) David Lagares et al. Science Translational Medicine
- A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease
- (2017) Dimitrios Daoussis et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Nrf2 exerts cell-autonomous antifibrotic effects: compromised function in systemic sclerosis and therapeutic rescue with a novel heterocyclic chalcone derivative
- (2017) Jun Wei et al. Translational Research
- TGF-β1 Signaling and Tissue Fibrosis
- (2017) Kevin K. Kim et al. Cold Spring Harbor Perspectives in Biology
- Review: Frontiers of Antifibrotic Therapy in Systemic Sclerosis
- (2017) Jörg H. W. Distler et al. Arthritis & Rheumatology
- Belimumab for the Treatment of Early Diffuse Systemic Sclerosis
- (2017) Jessica K. Gordon et al. Arthritis & Rheumatology
- CCL2 in the Circulation Predicts Long-Term Progression of Interstitial Lung Disease in Patients With Early Systemic Sclerosis: Data From Two Independent Cohorts
- (2017) Minghua Wu et al. Arthritis & Rheumatology
- Association of MicroRNA-618 Expression With Altered Frequency and Activation of Plasmacytoid Dendritic Cells in Patients With Systemic Sclerosis
- (2017) Marzia Rossato et al. Arthritis & Rheumatology
- Efficacy and Safety of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis
- (2017) Christopher P. Denton et al. Arthritis & Rheumatology
- New advances in the understanding and treatment of axial spondyloarthritis: from chance to choice
- (2017) Sayam Dubash et al. Therapeutic Advances in Chronic Disease
- Differential impact of the dual CCR2/CCR5 inhibitor cenicriviroc on migration of monocyte and lymphocyte subsets in acute liver injury
- (2017) Tobias Puengel et al. PLoS One
- Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease
- (2017) Viktor Martyanov et al. PLoS One
- Dimethyl Fumarate ameliorates pulmonary arterial hypertension and lung fibrosis by targeting multiple pathways
- (2017) Agnieszka P. Grzegorzewska et al. Scientific Reports
- Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosis
- (2016) Matthieu Ponsoye et al. ANNALS OF THE RHEUMATIC DISEASES
- Update of EULAR recommendations for the treatment of systemic sclerosis
- (2016) Otylia Kowal-Bielecka et al. ANNALS OF THE RHEUMATIC DISEASES
- Regulatory T Cells in Systemic Sclerosis: a Comprehensive Review
- (2016) Gleb Slobodin et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Cannabinoids, inflammation, and fibrosis
- (2016) Robert B. Zurier et al. FASEB JOURNAL
- Macrophages in Tissue Repair, Regeneration, and Fibrosis
- (2016) Thomas A. Wynn et al. IMMUNITY
- Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis
- (2016) Dinesh Khanna et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial
- (2016) D. Khanna et al. JOURNAL OF RHEUMATOLOGY
- Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
- (2016) Dinesh Khanna et al. LANCET
- Reducing the risk of failure: biomarker-guided trial design
- (2016) Michael J. Townsend et al. NATURE REVIEWS DRUG DISCOVERY
- Regulation of the Bioavailability of TGF-β and TGF-β-Related Proteins
- (2016) Ian B. Robertson et al. Cold Spring Harbor Perspectives in Biology
- SIRT3 is attenuated in systemic sclerosis skin and lungs, and its pharmacologic activation mitigates organ fibrosis
- (2016) Kaname Akamata et al. Oncotarget
- Cellular Therapies in Systemic Sclerosis: Recent Progress
- (2016) Femke C. C. van Rhijn-Brouwer et al. Current Rheumatology Reports
- Breg Cells Are Numerically Decreased and Functionally Impaired in Patients With Systemic Sclerosis
- (2016) Athanasios Mavropoulos et al. Arthritis & Rheumatology
- Toll-like Receptor 9 Signaling Is Augmented in Systemic Sclerosis and Elicits Transforming Growth Factor β-Dependent Fibroblast Activation
- (2016) Feng Fang et al. Arthritis & Rheumatology
- Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
- (2016) Donald P Tashkin et al. Lancet Respiratory Medicine
- Redox mechanisms in age-related lung fibrosis
- (2016) Ashish Kurundkar et al. Redox Biology
- The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs
- (2015) Yi Zhu et al. AGING CELL
- Sustained Activation of Toll-Like Receptor 9 Induces an Invasive Phenotype in Lung Fibroblasts
- (2015) Varvara Kirillov et al. AMERICAN JOURNAL OF PATHOLOGY
- The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis
- (2015) Zana Brkic et al. ANNALS OF THE RHEUMATIC DISEASES
- Polymorphisms in STAT4 and IRF5 increase the risk of systemic sclerosis: a meta-analysis
- (2015) Yang Xu et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis
- (2015) Katherine G. MacDonald et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Dimethyl Fumarate Inhibits the Nuclear Factor κB Pathway in Breast Cancer Cells by Covalent Modification of p65 Protein
- (2015) Irida Kastrati et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients
- (2015) Lisa M. Rice et al. JOURNAL OF CLINICAL INVESTIGATION
- Dissecting fibrosis: therapeutic insights from the small-molecule toolbox
- (2015) Carmel B. Nanthakumar et al. NATURE REVIEWS DRUG DISCOVERY
- Decreased levels of regulatory B cells in patients with systemic sclerosis: association with autoantibody production and disease activity
- (2015) Takashi Matsushita et al. RHEUMATOLOGY
- A candidate gene study reveals association between a variant of the Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) gene and systemic sclerosis
- (2015) Roberta Goncalves Marangoni et al. ARTHRITIS RESEARCH & THERAPY
- Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial
- (2015) Jessica K. Gordon et al. ARTHRITIS RESEARCH & THERAPY
- The Histone Deacetylase Sirtuin 1 Is Reduced in Systemic Sclerosis and Abrogates Fibrotic Responses by Targeting Transforming Growth Factor β Signaling
- (2015) Jun Wei et al. Arthritis & Rheumatology
- Increased Expression of NAPDH Oxidase 4 in Systemic Sclerosis Dermal Fibroblasts: Regulation by Transforming Growth Factor β
- (2015) Sonsoles Piera-Velazquez et al. Arthritis & Rheumatology
- A Reactive Oxygen Species-Mediated Loop Maintains Increased Expression of NADPH Oxidases 2 and 4 in Skin Fibroblasts From Patients With Systemic Sclerosis
- (2015) Tatiana Spadoni et al. Arthritis & Rheumatology
- Systemic Sclerosis Patients Present Alterations in the Expression of Molecules Involved in B-Cell Regulation
- (2015) Lilian Soto et al. Frontiers in Immunology
- Systemic sclerosis
- (2015) Yannick Allanore et al. Nature Reviews Disease Primers
- Cellular Mechanisms of Tissue Fibrosis. 8. Current and future drug targets in fibrosis: focus on Rho GTPase-regulated gene transcription
- (2014) Pei-Suen Tsou et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Sirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosis
- (2014) Pawel Zerr et al. ANNALS OF THE RHEUMATIC DISEASES
- Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
- (2014) Suzana Jordan et al. ANNALS OF THE RHEUMATIC DISEASES
- Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis
- (2014) Jacob M. van Laar et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Long-term beneficial effects of statins on vascular manifestations in patients with systemic sclerosis
- (2014) Masataka Kuwana et al. Modern Rheumatology
- Transforming growth factor β—at the centre of systemic sclerosis
- (2014) Robert Lafyatis Nature Reviews Rheumatology
- Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis
- (2014) Lucille Desallais et al. ARTHRITIS RESEARCH & THERAPY
- Amelioration of Tissue Fibrosis by Toll-like Receptor 4 Knockout in Murine Models of Systemic Sclerosis
- (2014) Takehiro Takahashi et al. Arthritis & Rheumatology
- Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis
- (2013) Michal Tomcik et al. ANNALS OF THE RHEUMATIC DISEASES
- Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis
- (2013) Christian Beyer et al. ANNALS OF THE RHEUMATIC DISEASES
- Review: Evidence That Systemic Sclerosis Is a Vascular Disease
- (2013) Marco Matucci-Cerinic et al. ARTHRITIS AND RHEUMATISM
- Peripheral blood regulatory T cells in patients with diffuse systemic sclerosis (SSc) before and after autologous hematopoietic SCT: a pilot study
- (2013) J Baraut et al. BONE MARROW TRANSPLANTATION
- Current status of systemic sclerosis biomarkers: applications for diagnosis, management and drug development
- (2013) Flavia V Castelino et al. Expert Review of Clinical Immunology
- Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
- (2013) Tomás Pulido et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis
- (2013) Lenny van Bon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence of Anti-RNA Polymerase III Antibodies in Systemic Sclerosis: New Data From a French Cohort and a Systematic Review and Meta-Analysis
- (2013) Vincent Sobanski et al. Arthritis & Rheumatology
- Association of Interferon- and Transforming Growth Factor β-Regulated Genes and Macrophage Activation With Systemic Sclerosis-Related Progressive Lung Fibrosis
- (2013) Romy B. Christmann et al. Arthritis & Rheumatology
- Recent Developments in Myofibroblast Biology
- (2012) Boris Hinz et al. AMERICAN JOURNAL OF PATHOLOGY
- Toll-Like Receptor 4 Signaling Augments Transforming Growth Factor-β Responses
- (2012) Swati Bhattacharyya et al. AMERICAN JOURNAL OF PATHOLOGY
- Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study
- (2012) Muriel Elhai et al. ANNALS OF THE RHEUMATIC DISEASES
- Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomised, placebo controlled clinical trial
- (2012) Paul P Tak et al. ANNALS OF THE RHEUMATIC DISEASES
- Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis
- (2012) Estrella Garcia Gonzalez et al. ANNALS OF THE RHEUMATIC DISEASES
- Correlation of interferon-inducible chemokine plasma levels with disease severity in systemic sclerosis
- (2012) Xiaochun Liu et al. ARTHRITIS AND RHEUMATISM
- Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis
- (2012) Angelika Horn et al. ARTHRITIS AND RHEUMATISM
- JAK-2 as a novel mediator of the profibrotic effects of transforming growth factor β in systemic sclerosis
- (2012) Clara Dees et al. ARTHRITIS AND RHEUMATISM
- Wnt/β-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells
- (2012) Jun Wei et al. ARTHRITIS AND RHEUMATISM
- Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension
- (2012) Gérald Simonneau et al. EUROPEAN RESPIRATORY JOURNAL
- MicroRNA-29: a potential therapeutic target for systemic sclerosis
- (2012) Wen-Jia Peng et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- T cells in systemic sclerosis: a reappraisal
- (2012) S. O'Reilly et al. RHEUMATOLOGY
- The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy
- (2012) Feng Fang et al. ARTHRITIS RESEARCH & THERAPY
- Blockade of Interleukin-6 Receptor Alleviates Disease in Mouse Model of Scleroderma
- (2011) Shun Kitaba et al. AMERICAN JOURNAL OF PATHOLOGY
- Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial
- (2011) R. F. Spiera et al. ANNALS OF THE RHEUMATIC DISEASES
- Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease
- (2011) Galina S. Bogatkevich et al. ARTHRITIS AND RHEUMATISM
- Imatinib in active diffuse cutaneous systemic sclerosis: Results of a six-month, randomized, double-blind, placebo-controlled, proof-of-concept pilot study at a single center
- (2011) Janet Pope et al. ARTHRITIS AND RHEUMATISM
- Role of IL-13 in systemic sclerosis
- (2011) Patrizia Fuschiotti CYTOKINE
- Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial
- (2011) Richard K Burt et al. LANCET
- Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities
- (2011) Swati Bhattacharyya et al. Nature Reviews Rheumatology
- Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness: a cross-sectional study
- (2011) Tatiana S. Rodríguez-Reyna et al. RHEUMATOLOGY INTERNATIONAL
- Immunological reconstitution after autologous stem cell transplantation in patients with refractory systemic autoimmune diseases
- (2011) P Szodoray et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease
- (2011) Marie-Elise Truchetet et al. ARTHRITIS RESEARCH & THERAPY
- The monoclonal anti-CD25 antibody basiliximab for the treatment of progressive systemic sclerosis: an open-label study
- (2010) M. O. Becker et al. ANNALS OF THE RHEUMATIC DISEASES
- Regulatory T cells (CD4+CD25brightFoxP3+) expansion in systemic sclerosis correlates with disease activity and severity
- (2010) Gleb Slobodin et al. CELLULAR IMMUNOLOGY
- Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease
- (2010) Maria De Santis et al. Clinical Respiratory Journal
- Elevated serum levels of a proliferation-inducing ligand in patients with systemic sclerosis: Possible association with myositis?
- (2010) Iman H. Bassyouni et al. JOINT BONE SPINE
- Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression
- (2010) Fei Liu et al. JOURNAL OF CELL BIOLOGY
- Dicer Insufficiency and MicroRNA-155 Overexpression in Lupus Regulatory T Cells: An Apparent Paradox in the Setting of an Inflammatory Milieu
- (2010) A. A. Divekar et al. JOURNAL OF IMMUNOLOGY
- Increased Production of a Proliferation-inducing Ligand (APRIL) by Peripheral Blood Mononuclear Cells Is Associated with Antitopoisomerase I Antibody and More Severe Disease in Systemic Sclerosis
- (2010) M. BIELECKI et al. JOURNAL OF RHEUMATOLOGY
- Lack of effect of 8 weeks atorvastatin on microvascular endothelial function in patients with systemic sclerosis
- (2010) H. Y. Sadik et al. RHEUMATOLOGY
- TLR9 Differentiates Rapidly from Slowly Progressing Forms of Idiopathic Pulmonary Fibrosis
- (2010) G. Trujillo et al. Science Translational Medicine
- Rosiglitazone Abrogates Bleomycin-Induced Scleroderma and Blocks Profibrotic Responses Through Peroxisome Proliferator-Activated Receptor-γ
- (2009) Minghua Wu et al. AMERICAN JOURNAL OF PATHOLOGY
- STAT4is a genetic risk factor for systemic sclerosis having additive effects withIRF5on disease susceptibility and related pulmonary fibrosis
- (2009) P. Dieudé et al. ARTHRITIS AND RHEUMATISM
- Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis
- (2009) Alfiya Akhmetshina et al. ARTHRITIS AND RHEUMATISM
- A TGFβ-Responsive Gene Signature Is Associated with a Subset of Diffuse Scleroderma with Increased Disease Severity
- (2009) Jennifer L. Sargent et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Transforming growth factor β as a therapeutic target in systemic sclerosis
- (2009) John Varga et al. Nature Reviews Rheumatology
- Scleroderma
- (2009) Armando Gabrielli et al. NEW ENGLAND JOURNAL OF MEDICINE
- A non-Smad mechanism of fibroblast activation by transforming growth factor-β via c-Abl and Egr-1: selective modulation by imatinib mesylate
- (2009) S Bhattacharyya et al. ONCOGENE
- Endothelial/lymphocyte activation leads to prominent CD4+ T cell infiltration in the gastric mucosa of patients with systemic sclerosis
- (2008) Mirko Manetti et al. ARTHRITIS AND RHEUMATISM
- Modulation of CCR2 in rheumatoid arthritis: A double‐blind, randomized, placebo‐controlled clinical trial
- (2008) Clarissa E. Vergunst et al. ARTHRITIS AND RHEUMATISM
- Can CCL2 serum levels be used in risk stratification or to monitor treatment response in systemic sclerosis?
- (2007) M T Carulli et al. ANNALS OF THE RHEUMATIC DISEASES
- CXCL10 ( ) and CCL2 ( ) chemokines in systemic sclerosis a longitudinal study
- (2007) A. Antonelli et al. RHEUMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now